The global
Pain
Management Therapeutics Market size is estimated to generate revenues of more
than USD 107.3 billion by 2030, growing at a CAGR of
around 4.3% from 2021 to 2030
The report covers SWOT analysis, market valuation, competitive spectrum,
regional share, and revenue predictions. The
report offers an analysis of the global pain management therapeutics Market for
the period 2016 to 2030, wherein 2021 to 2030 is the forecast period and 2020
is considered as the base year.
The wide application portfolio of pain management therapeutics market is
one of factors driving the growth of market worldwide. The global market is
moderately competitive with a blend of global and regional players. The markets
key players invest significantly in R and D to enhance their offerings. The
entire ecosystem is composed of multiple participants. Every participant of the
ecosystem is an equal contributor to the growth of global market.
Why should you
invest in this report?
If you are aiming to enter the global pain management
therapeutics Market, this report is a comprehensive guide that provides crystal
clear insights into this niche market. All the major application areas for pain
management therapeutics are covered in this report and information is given on
the important regions of the world where this market is likely to boom during
the forecast period of 2021-2030, so that you can plan your strategies to enter
this market accordingly. Besides, through this report, you can have a complete
grasp of the level of competition you will be facing in this hugely competitive
market and if you are an established player in this market already, this report
will help you gauge the strategies that your competitors have adopted to stay
as market leaders in this market. For new entrants to this market, the
voluminous data provided in this report is invaluable.
Report Structure:
- pertinent
market numbers of the global pain management therapeutics market along
with the CAGR for the forecast period 2021-2030
- detailed
definitions of different types of pain management therapeutics, which
gives clarity about what this market is all about and also defines the
scope of this report
- macroeconomic
factors influencing the global pain management therapeutics market, along
with market opportunity analysis
- key
trends likely to impact the global pain management therapeutics market
- PESTLE
analysis of all the regions as per the market taxonomy
- Porter’s
Five Force Analysis of all the regions as given in the market taxonomy
Global market analysis and forecast:
- the
global pain management therapeutics market analysis and forecast by
product type, by application, by region and others
- key
market metrics such as the BPS analysis, year-on-year growth rates,
absolute dollar opportunity and market attractiveness analysis of the
global pain management therapeutics market
Regional market analysis and forecast:
- Regional
pain management therapeutics market analysis and forecast
- Regional
market dynamics including the drivers, restraints and trends applicable
across different regions in the pain management therapeutics market along
with factors encouraging the growth of this market as well as the factors
hampering the growth of this market
- Regional
trends – both long term and short term
View Full Report@
https://www.precedenceresearch.com/pain-management-therapeutics-market
Competitive landscape:
- the
competitive landscape of this global report
- information
on the various leading companies in the global market
- a
dashboard view of the key companies operating in the global market along
with their important information and broad strategy adopted to stay as
leaders in the global market
- key
company profiles along with important information such as company details,
company description, product portfolio along with key developments
concerning the company and strategic analysis
Some of the prominent players in pain
management therapeutics market include:
- Teva
Pharmaceutical
- Pfizer
- Abbott
- Mallinckrodt
Pharmaceuticals
- Endo
International
- GlaxoSmithKline
- AstraZeneca
- Depomed
- Merck
- Novartis
Market Segmentation:
By Drug Class
- NSAIDs
- Opioids
- Anesthetics
- Antidepressants
- Anticonvulsants
- Others
By Indication
- Arthritic
Pain
- Neuropathic
Pain
- Chronic
Back Pain
- Post-Operative
Pain
- Cancer
Pain
- Others
By Distribution Channel
- Online
Pharmacy
- Retail
Pharmacy
- Hospital
Pharmacy
By Geography
- North
America
·
o
- U.S.
- Canada
- Europe
o
- Germany
- France
- United
Kingdom
- Rest
of Europe
- Asia
Pacific
o
- China
- Japan
- India
- Southeast
Asia
- Rest
of Asia Pacific
- Latin
America
o
- Brazil
- Rest
of Latin America
- Middle
East & Africa (MEA)
o
- GCC
- North
Africa
- South
Africa
- Rest
of Middle East & Africa
Research Methodology
In this report, historical data, primary responses and public
domain data has been thoroughly analyzed to infer the market size. Revenue of
companies operating in the global market has been benchmarked to ascertain the
market size for the base year. Macroeconomic indicators such as GDP and
industry growth have been considered to determine the market size for the
forecast period. The historical growth trend of end-use industries, market
participants’ performance, as well as the present macro-economic outlook has
been taken into consideration for estimating the overall market trend forecast.
This data is then validated using the triangulation method and extensively
scrutinized using advanced tools to garner quantitative and qualitative
insights into the global pain management therapeutics.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter
2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter
3. Executive Summary
3.1. Market Snapshot
Chapter
4. Pain Management Therapeutics Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter
5. COVID 19 Impact on Pain Management Therapeutics Market
5.1. Covid-19: Pain Management Therapeutics Industry Impact
5.2. Pain Management Therapeutics Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Pain Management Therapeutics Opportunities in the
COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Pain Management Therapeutics Market Players to deal with
Covid-19 Pandemic Scenario
Chapter
6. Pain Management Therapeutics Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Growing prevalence of chronic disorders
6.1.1.2. Increasing geriatric population
6.1.2. Market Restraints
6.1.2.1. Side-effects associated with some pain management medications
6.1.3. Market Opportunities
6.1.3.1. Growing research and development expenditure
6.1.3.2. Technological advancements
Chapter
7. Global Pain Management Therapeutics Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Pain Management Therapeutics Market Revenue by Market Players (2016
-2019)
7.1.1.2. Pain Management Therapeutics Market Revenue Market Share by Market
Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Drug Class
Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter
8. Global Pain Management Therapeutics Market, By Drug Class
8.1. Pain Management Therapeutics Market, by Drug Class, 2017 -
2030
8.1.1. NSAIDs
8.1.1.1. Market Revenue and Forecast (2017 - 2030)
8.1.2. Opioids
8.1.2.1. Market Revenue and Forecast (2017 - 2030)
8.1.3. Anesthetics
8.1.3.1. Market Revenue and Forecast (2017 - 2030)
8.1.4. Antidepressants
8.1.4.1. Market Revenue and Forecast (2017 - 2030)
8.1.5. Anticonvulsants
8.1.5.1. Market Revenue and Forecast (2017 - 2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017 - 2030)
Chapter
9. Global Pain Management Therapeutics Market, By Indication
9.1. Pain Management Therapeutics Market, by Indication, 2017 -
2030
9.1.1. Arthritic Pain
9.1.1.1. Market Revenue and Forecast (2017 - 2030)
9.1.2. Neuropathic Pain
9.1.2.1. Market Revenue and Forecast (2017 - 2030)
9.1.3. Chronic Back Pain
9.1.3.1. Market Revenue and Forecast (2017 - 2030)
9.1.4. Post-Operative Pain
9.1.4.1. Market Revenue and Forecast (2017 - 2030)
9.1.5. Cancer Pain
9.1.5.1. Market Revenue and Forecast (2017 - 2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2017 - 2030)
Chapter
10. Global Pain Management Therapeutics Market, By Distribution Channel
10.1. Pain Management Therapeutics Market, by Distribution
Channel, 2017 - 2030
10.1.1. Online Pharmacy
10.1.1.1. Market Revenue and Forecast (2017 - 2030)
10.1.2. Retail Pharmacy
10.1.2.1. Market Revenue and Forecast (2017 - 2030)
10.1.3. Hospital Pharmacy
10.1.3.1. Market Revenue and Forecast (2017 - 2030)
Chapter
11. Global Pain Management Therapeutics Market, Regional Estimates and Trend
Forecast
11.1. North America
11.1.1. Market Revenue Forecast by Drug Class(2017 - 2030)
11.1.2. Market Revenue Forecast by Indication(2017 - 2030)
11.1.3. Market Revenue Forecast by Distribution Channel (2017 - 2030)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2017 - 2030)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2017 - 2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Drug Class (2017 - 2030)
11.2.2. Market Revenue Forecast by Indication (2017 - 2030)
11.2.3. Market Revenue Forecast by Distribution Channel (2017 - 2030)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2017 - 2030)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2017 - 2030)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2017 - 2030)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2017 - 2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Drug Class (2017 - 2030)
11.3.2. Market Revenue Forecast by Indication (2017 - 2030)
11.3.3. Market Revenue Forecast by Distribution Channel (2017 - 2030)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2017 - 2030)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2017 - 2030)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2017 - 2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2017 - 2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Drug Class (2017 - 2030)
11.4.2. Market Revenue Forecast by Indication (2017 - 2030)
11.4.3. Market Revenue Forecast by Distribution Channel (2017 - 2030)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2017 - 2030)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2017 - 2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Drug Class (2017 - 2030)
11.5.2. Market Revenue Forecast by Indication (2017 - 2030)
11.5.3. Market Revenue Forecast by Distribution Channel (2017 - 2030)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2017 - 2030)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2017 - 2030)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2017 - 2030)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2017 - 2030)
Chapter
12. Company Profiles
12.1. Teva Pharmaceutical
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Distribution Channel
12.1.3. Revenue, Price, and Gross Margin (2017 - 2020)
12.1.4. Recent Developments and Strategies
12.2. Pfizer
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Distribution Channel
12.2.3. Revenue, Price, and Gross Margin (2017 - 2020)
12.2.4. Recent Developments and Strategies
12.3. Abbott
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Distribution Channel
12.3.3. Revenue, Price, and Gross Margin (2017 - 2020)
12.3.4. Recent Developments and Strategies
12.4. Mallinckrodt Pharmaceuticals
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Distribution Channel
12.4.3. Revenue, Price, and Gross Margin (2017 - 2020)
12.4.4. Recent Developments and Strategies
12.5. Endo International
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Distribution Channel
12.5.3. Revenue, Price, and Gross Margin (2017 - 2020)
12.5.4. Recent Developments and Strategies
12.6. GlaxoSmithKline
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Distribution Channel
12.6.3. Revenue, Price, and Gross Margin (2017 - 2020)
12.6.4. Recent Developments and Strategies
12.7. AstraZeneca
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Distribution Channel
12.7.3. Revenue, Price, and Gross Margin (2017 - 2020)
12.7.4. Recent Developments and Strategies
12.8. Depomed
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Distribution Channel
12.8.3. Revenue, Price, and Gross Margin (2017 - 2020)
12.8.4. Recent Developments and Strategies
12.9. Merck
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Distribution Channel
12.9.3. Revenue, Price, and Gross Margin (2017 - 2020)
12.9.4. Recent Developments and Strategies
12.10. Novartis
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Distribution Channel
12.10.3. Revenue, Price, and Gross Margin (2017 - 2020)
12.10.4. Recent Developments and Strategies
Chapter
13. Appendix
13.1. About Us
13.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: http://www.marketstatsnews.com/
